1. Home
  2. DALN vs NSPR Comparison

DALN vs NSPR Comparison

Compare DALN & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DALN
  • NSPR
  • Stock Information
  • Founded
  • DALN 1954
  • NSPR 2005
  • Country
  • DALN United States
  • NSPR United States
  • Employees
  • DALN N/A
  • NSPR N/A
  • Industry
  • DALN Newspapers/Magazines
  • NSPR Medical/Dental Instruments
  • Sector
  • DALN Consumer Discretionary
  • NSPR Health Care
  • Exchange
  • DALN Nasdaq
  • NSPR Nasdaq
  • Market Cap
  • DALN 73.2M
  • NSPR 74.8M
  • IPO Year
  • DALN 2008
  • NSPR N/A
  • Fundamental
  • Price
  • DALN $14.94
  • NSPR $2.45
  • Analyst Decision
  • DALN
  • NSPR Strong Buy
  • Analyst Count
  • DALN 0
  • NSPR 2
  • Target Price
  • DALN N/A
  • NSPR $4.50
  • AVG Volume (30 Days)
  • DALN 379.5K
  • NSPR 110.2K
  • Earning Date
  • DALN 07-30-2025
  • NSPR 08-05-2025
  • Dividend Yield
  • DALN N/A
  • NSPR N/A
  • EPS Growth
  • DALN N/A
  • NSPR N/A
  • EPS
  • DALN N/A
  • NSPR N/A
  • Revenue
  • DALN $121,119,000.00
  • NSPR $7,066,000.00
  • Revenue This Year
  • DALN N/A
  • NSPR $4.85
  • Revenue Next Year
  • DALN N/A
  • NSPR $113.47
  • P/E Ratio
  • DALN N/A
  • NSPR N/A
  • Revenue Growth
  • DALN N/A
  • NSPR 7.60
  • 52 Week Low
  • DALN $3.66
  • NSPR $1.99
  • 52 Week High
  • DALN $16.10
  • NSPR $3.80
  • Technical
  • Relative Strength Index (RSI)
  • DALN 80.61
  • NSPR 49.34
  • Support Level
  • DALN $14.79
  • NSPR $2.37
  • Resistance Level
  • DALN $15.10
  • NSPR $2.93
  • Average True Range (ATR)
  • DALN 0.20
  • NSPR 0.19
  • MACD
  • DALN -0.23
  • NSPR 0.02
  • Stochastic Oscillator
  • DALN 53.04
  • NSPR 30.43

About DALN DallasNews Corporation Series A

DallasNews Corp is a local news and information publishing company. It operates The Dallas Morning News (dallasnews.com), Texas' newspaper. These operations generate revenue from advertising sales within the company's newspaper and digital platforms, subscriptions and retail sales of its newspaper, and commercial printing and distribution services predominantly related to national newspapers. In addition to traditional print and digital advertising, the company has a full-service agency, Medium Giant, offering businesses comprehensive, strategic, and creative marketing solutions. The company's two reportable segments are TDMN and Agency. Maximum revenue is derived from the TDMN segment, which comprises its traditional print business. The firm's customer base is concentrated in North Texas.

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

Share on Social Networks: